早期鼻腔NK/T细胞淋巴瘤三组放射治疗剂量的效果比较

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the effects of different radiotherapy doses on the early stage nasal NK/T cell lymphoma. Methods 64 patients with early stage nasal NK/T cell lymphoma undergoing radiotherapy were divided into <50 Gy group(n=20), 51-60 Gy group(n=24) and ＞60 Gy group(n=20), all groups were observed and their local control rate and survival rate of 5 years were compared. Results The total local control rates in the three groups were 68.5%, 82.5% and 72.2% respectively. There was significant difference in the local control rate and survival rate of 5 years between＜50 Gy group and the other two groups (51-60 Gy and ＞60 Gy group) (P＜0.05), but the differences between the two groups were not statistically significant. Conclusions 51-60 Gy doses of radiation can guarantee good local control rate, improve overall survival rate. The choice of radiation doses to 50 Gy in patients with early stage nasal NK/T cell lymphoma is appropriate, with clinical recommendations.

Key words： lymphoma nasal cavity NK/T cell lymphoma radiotherapy prognosis

Received: 27 July 2013

ZTFLH:

R816.96

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WU Li-Zhou
	LIU Han-Shan
	CAI Wei

Cite this article:

WU Li-Zhou,LIU Han-Shan,CAI Wei. Comparison of effect of three radiation doses for early stage nasal NK/T cell lymphoma[J]. , 2014, 25(6): 560-561.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2014/V25/I6/560

[5]	Koom W S,Yang W I.Angiocentric t-CELL and NK/T-cell Lymphomas:radiotheraptic viewpoints[J].Int J Radiat Oncol Biol Phys,2004,59(4):1127-1137.
[6]	张小建,蒋国梁,曹军宁.鼻腔非霍奇金淋巴瘤的综合治疗[J].中华放射肿瘤学杂志,2000,9(3):162-165.
[1]	马辉辉,张红雁,钱立庭.71例鼻腔NK/T细胞淋巴瘤放化疗效和预后因素分析[J].中华放射肿瘤学杂志,2010,23(1):107-109.
[7]	钟睿,陈志萍,邬蒙.Ⅰ、Ⅱ期鼻腔非霍奇金淋巴瘤的预后[J].肿瘤防治杂志,2007,8(4):416-417.
[2]	邹丽芬,程庆芳.鼻腔非霍奇金淋巴瘤的治疗[J].复旦学报(科学版),2009,28(7):363-365.
[3]	Isobe K,Uno T,Tamaru J,et al.Extranodal natural killer/T-cellymphoma,naal type:the significance of radiotherapeutic parameters[J].Cancer,2006,106:609-615.
[4]	汪华,李晔雄,王维虎,等.早期鼻腔和韦氏环NK/T细胞淋巴瘤调强放疗的初步结果[J].中华放射肿瘤学杂志,2010,19(2):67-68.
[5]	Koom W S,Yang W I.Angiocentric t-CELL and NK/T-cell Lymphomas:radiotheraptic viewpoints[J].Int J Radiat Oncol Biol Phys,2004,59(4):1127-1137.
[6]	张小建,蒋国梁,曹军宁.鼻腔非霍奇金淋巴瘤的综合治疗[J].中华放射肿瘤学杂志,2000,9(3):162-165.
[7]	钟睿,陈志萍,邬蒙.Ⅰ、Ⅱ期鼻腔非霍奇金淋巴瘤的预后[J].肿瘤防治杂志,2007,8(4):416-417.